Clin2
NCT07213466Possibly a fitRecruiting

Personalized weight-loss medication for bipolar disorder

Bipolar I DisorderBipolar II DisorderSchizo Affective DisorderObesityWeight LossGLP - 1

Treatments studied

Part of Hormones & metabolism, Mental health clinical trials.

This study wants to see if a personalized approach with FDA-approved weight-loss medications can help people with bipolar disorder who are overweight or have obesity, while staying on their mood stabilizer treatment. It might be a good fit if you have bipolar disorder and struggle with your weight.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 to 65 years old
  • You have bipolar I, bipolar II, or schizoaffective bipolar type (confirmed by a doctor)
  • You have been on a stable mood stabilizer for at least one month
  • You have a BMI of 30 or more, or a BMI of 27 or more plus a weight-related health problem
  • You have not had bariatric surgery (like gastric bypass or sleeve)
  • You do not have severe depression, mania, psychosis, or an eating disorder right now

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07770841Recruiting· Phase 3
Oral medication for weight loss study

This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.

Birmingham, Alabama
NCT07091500Recruiting
Exercise and a weight-loss drug for people with obesity

This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.

St Louis, Missouri
NCT06411210Recruiting· Phase 2
Weight loss medication for young adults with type 1 diabetes

This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.

New Haven, Connecticut
NCT07323134Not yet recruiting
Semaglutide for obesity and gut health

This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.

NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.

NCT07627074Recruiting
Real-world weight loss study with semaglutide

This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.

Seattle, Washington

Hear when a new Bipolar I Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.